Valuation Grand Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 04:08:09 2026-10-23 EDT			5-day change	1st Jan Change
4.455 ^HKD	+1.14%		-2.94%	-43.25%

08-26	Grand Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-10	Grand Pharma's Cancer Diagnostic Candidate Gets FDA Fast Track Status; Shares Jump 5%	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	22,930	16,225	14,394	16,809	27,489	15,425	-	-
Change	-	-29.24%	-11.29%	16.78%	63.54%	-43.89%	-	-
Enterprise Value (EV)	22,930	16,225	14,394	16,809	27,489	15,425	15,425	15,425
Change	-	-29.24%	-11.29%	16.78%	63.54%	-43.89%	0%	0%
P/E	-	-	7.63x	6.81x	22.2x	8.55x	7.83x	6.96x
PBR	1.71x	1.14x	0.94x	1.02x	1.62x	0.86x	0.81x	0.76x
PEG	-	-	-	0.2x	-0.4x	0.2x	0.85x	0.6x
Capitalization / Revenue	2.67x	1.7x	1.37x	1.44x	2.24x	1.19x	1.09x	0.98x
EV / Revenue	0x	0x	0x	0x	0x	1.19x	1.09x	0.98x
EV / EBITDA	0x	-	-	0x	0x	5.22x	4.91x	4.25x
EV / EBIT	0x	0x	0x	0x	0x	6.76x	6.21x	5.41x
EV / FCF	0x	0x	0x	0x	0x	8.5x	7.68x	7.12x
FCF Yield	6.69%	7.5%	13.5%	7.99%	3.36%	11.8%	13%	14%
Dividend per Share ²	-	0.14	0.26	0.26	0.169	0.21	0.23	0.32
Rate of return	-	3.04%	6.36%	5.42%	2.15%	4.77%	5.22%	7.26%
EPS ²	-	-	0.536	0.7049	0.3544	0.515	0.5625	0.6333
Distribution rate	-	-	48.5%	36.9%	47.7%	40.8%	40.9%	50.5%
Net sales ¹	8,598	9,562	10,530	11,645	12,283	12,944	14,102	15,717
EBITDA ¹	3,218	-	-	3,536	2,238	2,952	3,141	3,630
EBIT ¹	2,879	2,654	2,549	3,033	1,656	2,283	2,482	2,852
Net income ¹	-	-	1,880	2,468	1,241	1,826	1,991	2,244
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	6.460	4.600	4.090	4.800	7.850	4.405	4.405	4.405
Nbr of stocks (in thousands)	3,549,571	3,527,141	3,519,271	3,501,810	3,501,810	3,501,810	-	-
Announcement Date	3/17/22	3/22/23	3/19/24	3/12/25	3/26/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
GRAND PHARMACEUTICAL GROUP LIMITED	8.55x	-	-	4.77%	1.97B
ELI LILLY AND COMPANY	37.7x	13.43x	28.51x	0.52%	1,165B
JOHNSON & JOHNSON	39.17x	6.59x	18.54x	1.99%	645B
ABBVIE INC.	36.4x	8.37x	17.27x	2.41%	504B
ROCHE HOLDING AG	20.97x	5.15x	12.78x	2.55%	380B
MERCK & CO., INC.	107.33x	5.99x	25.72x	2.31%	363B
NOVARTIS AG	21.95x	5.71x	14.04x	2.79%	297B
ASTRAZENECA PLC	22.67x	4.58x	13.09x	1.93%	269B
AMGEN INC.	28.38x	7.14x	12.79x	2.26%	237B
GILEAD SCIENCES, INC.	-45.82x	7.02x	27.23x	2.1%	195B
Average	27.73x	7.11x	18.89x	2.36%	405.74B
Weighted average by Cap.	35.72x	8.44x	20.74x	1.78%